Scientists identify key protein that may cause cancer cell deathJanuary 17th, 2009 - 1:26 pm ICT by ANI
Washington, January 17 (ANI): An autonomous institute of the Agency for Science, Technology and Research in Singapore has announced the discovery of a human protein called Bax-beta (Baxa), which can potentially cause the death of cancer cells and lead to new approaches in cancer treatment.
“Our research findings reveal that Baxa protein levels are normally kept at essentially undetectable levels in healthy cells by the protein degradation machine in cells known as proteasomes, said Dr. Victor Yu, who led the Institute of Molecular and Cell Biology (IMCB) research team.
In a researcher article in the journal Molecular Cell, the researchers describe proteasomes as “protein-digesting machines” that regulate cellular levels of various proteins, including that of the lethal Baxa, by breaking them into smaller components within the cell.
“Thus, the proteasomes are there to keep the lethal Baxa in check. This is exciting if the proteasome-mediated degradation of Baxa could be inhibited specifically in cancer cells, it could cause the harmful cancer cells to go through apoptosis,” Dr. Victor Yu said.
In apoptosis, unwanted, damaged and infected cells are eliminated.
Before the discovery of Baxa, only one single protein called Bax-alpha (Baxa) had been extensively studied in cells.
The researchers have now found that Baxa is able to associate with, and promote, Baxa activation, and that Baxa, in its native form, is 100 times more potent than its sibling Baxa in triggering a key step in apoptosis.
They believe that the development of such compounds as can elevate levels of Baxa, or stimulate its interaction with Baxa, may pave the way for new drug approaches to cancer treatment, as these compounds are likely to enhance the apoptotic signals triggered by many conventional cancer drugs, which frequently cause toxic side effects in patients when higher doses of drugs are needed.
Dr. David Andrews, Professor of Biochemistry and Biomedical Sciences at McMaster University, Canada said: “The beta-isoform4 of Bax has been enigmatic for several years. Although earlier research had hinted at its existence, the protein has proven extremely difficult to detect or examine functionally. Even attempts to produce the protein in the laboratory have been largely unsuccessful. In this study the Yu group resolves these issues by demonstrating that in cells Baxa is normally rapidly degraded and kept at low levels, and when it is not degraded, it is profoundly apoptotic on its own and works in concert with Baxa. These studies provide information necessary for the elucidation of the importance of Baxa in cell physiology.” (ANI)
- Scientists discover key difference in 'kiss of death' sequence of TB bacteria - Oct 18, 2010
- New approach could reverse liver failure - Aug 06, 2012
- New hope for cancer cure - Jul 08, 2011
- Disrupting key structure in TB bacterium could aid in new drug design - May 12, 2010
- Why some body organs are more susceptible to cell death than others - Jan 25, 2011
- Protein discovery could lead to better autoimmune disease, cancer drugs - Mar 03, 2011
- New way to kill cancer cells discovered - Sep 18, 2011
- New discovery shows promise against non-small cell lung cancer - Dec 04, 2010
- Synthetic compound may lead to drugs to fight pancreatic, lung cancer - Mar 10, 2011
- Latin brew bumps off colon cancer cells - Jan 24, 2012
- New 'nanodrug' can attack breast cancer cells from the inside out - Mar 30, 2011
- Identification of protein that amplifies cell death may revolutionise cancer treatment - Jan 15, 2009
- Gene-silencing that could prevent diabetes-related heart failure - Dec 10, 2010
- Mushroom compound boosts cancer drug - Oct 12, 2011
- Protein that makes tumor cells in breast cancer resistant to treatments - Dec 15, 2010
Tags: apoptotic, autonomous institute, baxa, biom, cancer cell, cancer cells, cancer drugs, cancer treatment, cell death, cellular levels, dr david, human protein, institute of molecular and cell biology, molecular and cell biology, protein degradation, protein levels, research findings, sibling, toxic side effects, undetectable levels